Borchelt DR - Search Results

1

Regenerative medicine in Alzheimer's disease.

Felsenstein KM, Candelario KM, Steindler DA, Borchelt DR. Felsenstein KM, et al. Among authors: borchelt dr. Transl Res. 2014 Apr;163(4):432-8. doi: 10.1016/j.trsl.2013.11.001. Epub 2013 Nov 8. Transl Res. 2014. PMID: 24286919 Free PMC article. Review.

2

Cellular fusion for gene delivery to SCA1 affected Purkinje neurons.

Chen KA, Cruz PE, Lanuto DJ, Flotte TR, Borchelt DR, Srivastava A, Zhang J, Steindler DA, Zheng T. Chen KA, et al. Among authors: borchelt dr. Mol Cell Neurosci. 2011 May;47(1):61-70. doi: 10.1016/j.mcn.2011.03.003. Epub 2011 Mar 17. Mol Cell Neurosci. 2011. PMID: 21420496 Free PMC article.

3

A preclinical assessment of neural stem cells as delivery vehicles for anti-amyloid therapeutics.

Njie eG, Kantorovich S, Astary GW, Green C, Zheng T, Semple-Rowland SL, Steindler DA, Sarntinoranont M, Streit WJ, Borchelt DR. Njie eG, et al. Among authors: borchelt dr. PLoS One. 2012;7(4):e34097. doi: 10.1371/journal.pone.0034097. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496779 Free PMC article.

4

Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.

Melnikova T, Fromholt S, Kim H, Lee D, Xu G, Price A, Moore BD, Golde TE, Felsenstein KM, Savonenko A, Borchelt DR. Melnikova T, et al. Among authors: borchelt dr. J Neurosci. 2013 Feb 27;33(9):3765-79. doi: 10.1523/JNEUROSCI.4251-12.2013. J Neurosci. 2013. PMID: 23447589 Free PMC article.

5

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Price AR, Xu G, Siemienski ZB, Smithson LA, Borchelt DR, Golde TE, Felsenstein KM. Price AR, et al. Among authors: borchelt dr. Science. 2013 May 24;340(6135):924-d. doi: 10.1126/science.1234089. Science. 2013. PMID: 23704553

6

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.

Williams T, Borchelt DR, Chakrabarty P. Williams T, et al. Among authors: borchelt dr. Mol Neurodegener. 2020 Jan 31;15(1):8. doi: 10.1186/s13024-020-0358-9. Mol Neurodegener. 2020. PMID: 32005122 Free PMC article. Review.

7

Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.

Smit T, Deshayes NAC, Borchelt DR, Kamphuis W, Middeldorp J, Hol EM. Smit T, et al. Among authors: borchelt dr. Glia. 2021 Aug;69(8):1852-1881. doi: 10.1002/glia.23981. Epub 2021 Feb 25. Glia. 2021. PMID: 33634529 Free PMC article. Review.

8

Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis.

Xu G, Stevens SM Jr, Moore BD, McClung S, Borchelt DR. Xu G, et al. Among authors: borchelt dr. Hum Mol Genet. 2013 Jul 15;22(14):2765-74. doi: 10.1093/hmg/ddt121. Epub 2013 Mar 19. Hum Mol Genet. 2013. PMID: 23512986 Free PMC article.

9

Thinking laterally about neurodegenerative proteinopathies.

Golde TE, Borchelt DR, Giasson BI, Lewis J. Golde TE, et al. Among authors: borchelt dr. J Clin Invest. 2013 May;123(5):1847-55. doi: 10.1172/JCI66029. Epub 2013 May 1. J Clin Invest. 2013. PMID: 23635781 Free PMC article.

10

Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.

Xu G, Ran Y, Fromholt SE, Fu C, Yachnis AT, Golde TE, Borchelt DR. Xu G, et al. Among authors: borchelt dr. Acta Neuropathol Commun. 2015 Nov 14;3:72. doi: 10.1186/s40478-015-0252-9. Acta Neuropathol Commun. 2015. PMID: 26566997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters